Your browser doesn't support javascript.
loading
SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
Galiè, Nazzareno; Jansa, Pavel; Pulido, Tomás; Channick, Richard N; Delcroix, Marion; Ghofrani, Hossein-Ardeschir; Le Brun, Franck-Olivier; Mehta, Sanjay; Perchenet, Loïc; Rubin, Lewis J; Sastry, B K S; Simonneau, Gérald; Sitbon, Olivier; Souza, Rogério; Torbicki, Adam.
Afiliação
  • Galiè N; Department of Experimental, Diagnostic and Specialty Medicine-DIMES, via Massarenti 9, Bologna 40138, Italy.
  • Jansa P; Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, 2nd Medical Department, Charles University, Prague, Czech Republic.
  • Pulido T; Cardiopulmonary Department, Ignacio Chávez, National Heart Institute, Mexico City, Mexico.
  • Channick RN; Pulmonary and Critical Care, Massachusetts General Hospital, Boston, MA, USA.
  • Delcroix M; Department of Pneumology, Gasthuisberg University Hospital, Leuven, Belgium.
  • Ghofrani HA; University of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany, Member of the German Center of Lung Research (DZL), and Department of Medicine, Imperial College London, London, UK.
  • Le Brun FO; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland.
  • Mehta S; Division of Respirology, Department of Medicine, London Health Sciences Centre, Victoria Hospital, Western University, London, ON, Canada.
  • Perchenet L; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland.
  • Rubin LJ; Division of Pulmonary and Critical Care Medicine, University of California, San Diego Medical School, San Diego, CA, USA.
  • Sastry BKS; Department of Cardiology, CARE Hospitals, Hyderabad, India.
  • Simonneau G; Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Hôpital Bicêtre, Université Paris-Sud, Laboratoire d'Excellence en Recherche sur le Médicament et Innovation Thérapeutique, and INSERM U-999, Le Kremlin-Bicêtre, France.
  • Sitbon O; Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Hôpital Bicêtre, Université Paris-Sud, Laboratoire d'Excellence en Recherche sur le Médicament et Innovation Thérapeutique, and INSERM U-999, Le Kremlin-Bicêtre, France.
  • Souza R; Pulmonary Department, Heart Institute, University of São Paulo Medical School, São Paulo, Brazil.
  • Torbicki A; Department of Pulmonary Circulation and Thromboembolic Diseases, Medical Center for Postgraduate Education, ECZ-Otwock, Poland.
Eur Heart J ; 38(15): 1147-1155, 2017 04 14.
Article em En | MEDLINE | ID: mdl-28329315
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Antagonistas dos Receptores de Endotelina / Hemodinâmica / Hipertensão Pulmonar Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Antagonistas dos Receptores de Endotelina / Hemodinâmica / Hipertensão Pulmonar Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Eur Heart J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália